1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.54%
Positive revenue growth while RUN is negative. John Neff might see a notable competitive edge here.
-0.76%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-91.91%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
76.66%
Positive operating income growth while RUN is negative. John Neff might view this as a competitive edge in operations.
-94.39%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-94.87%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-94.44%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.06%
Share reduction more than 1.5x RUN's 0.39%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
-8.82%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
-119.63%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-13.53%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-50.04%
Negative 10Y revenue/share CAGR while RUN stands at 276.01%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-39.49%
Negative 5Y CAGR while RUN stands at 107.54%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-27.93%
Negative 3Y CAGR while RUN stands at 38.23%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-105.61%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-119.42%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-341.68%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
103.58%
Positive 10Y CAGR while RUN is negative. John Neff might see a substantial advantage in bottom-line trajectory.
101.07%
Positive 5Y CAGR while RUN is negative. John Neff might view this as a strong mid-term relative advantage.
22.42%
Positive short-term CAGR while RUN is negative. John Neff would see a clear advantage in near-term profit trajectory.
-60.55%
Negative equity/share CAGR over 10 years while RUN stands at 666.53%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
222.10%
5Y equity/share CAGR at 50-75% of RUN's 312.18%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
4848.85%
3Y equity/share CAGR above 1.5x RUN's 284.89%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative 5Y dividend/share CAGR while RUN stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
No Data
No Data available this quarter, please select a different quarter.
5.03%
Our AR growth while RUN is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
38.80%
Inventory growth well above RUN's 33.07%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
3.64%
Similar asset growth to RUN's 3.77%. Walter Schloss finds parallel expansions or investment rates.
1.53%
1.25-1.5x RUN's 1.16%. Bruce Berkowitz sees if the firm's capital management strategies surpass the competitor's approach.
1.70%
Debt shrinking faster vs. RUN's 4.56%. David Dodd sees a safer balance sheet if it doesn't impair future growth.
-18.04%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-5.70%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.